Development by genetic recombination of a line of Eimeria tenella resistant to robenidine, decoquinate and amprolium.
A line of Eimeria tenella (H) resistant to robenidine, decoquinate and amprolium has been produced by genetic recombination. It was not possible to obtain a cross between this line and lines resistant to clopidol or arprinocid and halofuginone. Recombination between lines resistant to arprinocid and halofuginone resulted in a loss of pathogenicity.
D000225:Adenine / Q000031:analogs & derivatives / Q000494:pharmacology; D000670:Amprolium / Q000494:pharmacology*; D000818:Animals; D002645:Chickens; D003007:Clopidol / Q000494:pharmacology; D003049:Coccidiostats / Q000494:pharmacology; D003667:Decoquinate / Q000494:pharmacology*; D004352:Drug Resistance, Microbial; D004539:Eimeria / Q000187:drug effects / Q000235:genetics* / Q000472:pathogenicity; D006146:Guanidines / Q000494:pharmacology*; D006912:Hydroxyquinolines / Q000494:pharmacology*; D010847:Picolines; D010880:Piperidines; D011799:Quinazolines / Q000494:pharmacology; D052999:Quinazolinones; D011995:Recombination, Genetic; D012370:Robenidine / Q000494:pharmacology*
D003049:Coccidiostats; D006146:Guanidines; D006912:Hydroxyquinolines; D010847:Picolines; D010880:Piperidines; D011799:Quinazolines; D052999:Quinazolinones; D012370:Robenidine; D003667:Decoquinate; C016245:arprinocid; D003007:Clopidol; D000670:Amprolium; D000225:Adenine; C010176:halofuginone